There are few issues where agreement is louder than when you ask Americans whether Congress ought to do more to lower the cost of prescription drugs. More than 160 million Americans receive healthcare benefits through work, and large employers pay more than 80 percent of the healthcare costs for their employees. These large plan sponsors […]
Author Archives: James Gelfand
James Gelfand is the CEO of the ERISA Industry Committee. He wrote this for InsideSources.com.
